SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is facing intense downward pressure despite a strong earnings beat and raised guidance, as investors react negatively to the surprise departure of its CFO and lingering concerns about AI disruption. The community is actively debating whether this sell-off is a classic market overreaction creating a deep-value buying opportunity or if Adobe is a long-term value trap in an AI-dominated market.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Market volatility surrounding the SPY is being driven by speculation over a potential US-Iran peace deal, alongside intense retail anticipation for the SpaceX IPO. Community discourse is sharply divided between those capitalizing on the rapid news-driven price swings and those expressing deep skepticism toward the recurring nature of these geopolitical headlines and the valuation of the upcoming space-tech listing.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

The SPDR Dow Jones Industrial Average ETF (DIA) is trending as investors grapple with conflicting signals from geopolitical tensions in the Middle East and mixed economic data, while the community intensely debates whether the market is detached from reality due to ongoing volatility and aggressive central bank policies. Traders remain focused on potential liquidity rotations ahead of major upcoming IPOs and significant inflationary pressure, reflecting a broader sentiment of skepticism regarding the current market rally.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is experiencing a surge in investor interest fueled by its position as a critical technology supplier to SpaceX and expectations surrounding the high-profile IPO in the space sector. The community is actively debating the stock's potential as a specialized proxy for aerospace innovation while split between optimistic long-term supporters citing defense contracts and skeptical traders highlighting concerns over past share dilution and profitability.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending due to its official inclusion in the Nasdaq-100, a milestone that community members believe will trigger significant forced institutional buying and validate the company's long-term growth potential. While retail sentiment remains highly divided between those betting on a parabolic breakout following the upcoming SpaceX IPO and others warning of a sell-the-news event, active discussions are focused on the stock's future role as a core infrastructure player in the expanding space economy.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech100 is trending due to intense market anticipation surrounding the upcoming SpaceX IPO, as investors view the fund as a key proxy for gaining exposure to SpaceX alongside other major AI and tech holdings like Anthropic and OpenAI. While the community is actively debating the impact of the fund's recent share offerings and potential dilution, bulls remain focused on the fund's private market access and potential NAV upside as these high-profile companies move toward public listings.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is seeing high volatility and intense community focus as traders debate whether it is a prime opportunity for a leveraged bounce or a risky play amid geopolitical tensions and memory chip market fluctuations. Investors are actively discussing its high sensitivity to the USD/KRW exchange rate and how it tracks the rapid shifts in South Koreas semiconductor sector.

EchoStar Corp. engages in the design, development, and distribution of digital set-top boxes and products for direct-to-home satellite service providers. It operates through the following business segments: Pay-TV, Retail Wireless, and Broadband and Satellite Services. The Pay-TV segment business strategy is to be the best provider of video services in the United States by providing products with the best technology, outstanding customer service, and great value. The Retail Wireless segment offers Retail Wireless services as well as a competitive portfolio of wireless devices. The Broadband and Satellite Services segment business strategy is to maintain and improve leadership position and competitive advantage through development of technologies and services marketed to selected sectors within the consumer, enterprise and government markets globally. The company was founded by Charlie William Ergen, Candy Ergen, and James DeFranco in 1980 and is headquartered in Englewood, CO.

EchoStar Corp - Ordinary Shares - Class A

EchoStar Corp

EchoStar is seeing heightened activity as investors position the stock as a primary public-market proxy for SpaceX's upcoming IPO, fueled by its significant spectrum deals and equity stake in the space firm. The community is actively debating the stock's valuation, potential for a short squeeze due to high short interest, and the impact of upcoming regulatory developments on its net asset value.

Entrepreneurshares Series Trust - ERShares Private-Public Crossover ETF

XOVR is trending as investors prioritize its exposure to SpaceX, with the community actively debating the ETF's valuation relative to its private holdings and its potential role as a liquid alternative to direct IPO participation. Traders are closely monitoring the fund's net asset value and structural concentration in private assets, balancing the excitement of upcoming public market entries against concerns over market volatility and sector-wide sentiment.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is capturing significant market attention following its formal inclusion in the Nasdaq-100 index, a milestone that community members view as a key catalyst for structural institutional demand and increased liquidity. While some participants are wary of historical insider selling and capital-intensive growth strategies, bullish investors remain focused on the companys massive revenue backlog and its critical role in expanding AI infrastructure capacity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

A Third Cancer Drug Just Entered the Clinic at an Under-$20-Million Company

A Third Cancer Drug Just Entered the Clinic at an Under-$20-Million Company A Third Cancer Drug Just Entered the Clinic at an Under-$20-Million Company PR Newswire SAN FRANCISCO, June 2, 2026 Equity Insider News CommentaryIssued on behalf of GT Biopharma, Inc. (NASDAQ: GTBP)SAN FRANCISCO, June 2...

Agenus Presents Phase 2 BOT+BAL Melanoma Data Showing Durable Responses and Meaningful Survival in Advanced Checkpoint-Refractory Melanoma at ASCO 2026

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the first disclosure of Phase 2 data from the C-800-23 study evaluating botensilimab (BOT), Agenus multifunctional Fc-enhanced anti-CTLA-4 antibody, with balstilimab (BAL), an anti-PD-1 antibody, in patients with...

Agenus and Noetik Present ASCO 2026 Data Linking AI Analysis of Routine Pretreatment Tumor Pathology Images to Response and Survival with BOT+BAL in MSS Metastatic CRC

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced new retrospective data showing that Noetiks artificial intelligence-based TARIO-2 model identified spatial tumor microenvironment patterns associated with clinical outcomes from routine pretreatment tumor pathology...

Agenus Announces Publication of Phase 1b Botensilimab and Balstilimab Data in Post-Immunotherapy Hepatocellular Carcinoma in Liver Cancer

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the publication of Phase 1b data evaluating botensilimab (BOT), an Fc-enhanced anti-CTLA-4 antibody, in combination...

Agenus Reports First Quarter 2026 Financial Results and Highlights BOT+BAL Execution Across Global Access and Phase 3 Development

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today reported financial results for the first quarter ended March 31, 2026, and provided an operational update on botensilimab...

MiNK Therapeutics, Inc. (NASDAQ:INKT) Given Consensus Recommendation of "Hold" by Analysts

MiNK Therapeutics, Inc. (NASDAQ:INKT - Get Free Report) has received an average rating of "Hold" from the five analysts that are presently covering the company, Marketbeat.com reports. One analyst...

Short Interest in MiNK Therapeutics, Inc. (NASDAQ:INKT) Drops By 30.6%

MiNK Therapeutics, Inc. (NASDAQ:INKT - Get Free Report) was the target of a significant decline in short interest in April. As of April 15th, there was short interest totaling 96,493 shares, a...

MiNK Therapeutics (NASDAQ:INKT) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen upgraded shares of MiNK Therapeutics to a "sell" rating in a research note on Saturday...

MiNK Therapeutics, Inc. (NASDAQ:INKT) Given Average Recommendation of "Hold" by Brokerages

MiNK Therapeutics, Inc. (NASDAQ:INKT - Get Free Report) has received a consensus rating of "Hold" from the five research firms that are presently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, two have given a hold rating, one has assigned a b...

HC Wainwright Issues Positive Outlook for INKT Earnings

MiNK Therapeutics, Inc. (NASDAQ:INKT - Free Report) - Equities researchers at HC Wainwright increased their Q1 2026 earnings per share estimates for shares of MiNK Therapeutics in a note issued to investors on Wednesday, April 1st. HC Wainwright analyst E. Bodnar now expects that the company will po...

MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded by Garo H. Armen in 2017 and is headquartered in New York, NY.

Current Price	$12.34
Prev Close	$12.19
Open	$11.65
Dividend Yield	0.00%
50-Day Moving Average	$11.56
Beta	0.62
Avg. Volume	39,470.19
PE Ratio	-4.35

52-Week High	$76.00
52-Week Low	$6.80
Market Capitalization	$60.73M
EPS (Annual)	-$2.93
Price to Book	-4.83
Revenue Per Employee	$0.00

INKTMiNK Therapeutics Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest INKT News